Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia

Gerald Andriole, Nicholas Bruchovsky, Leland W.K. Chung, Alvin M. Matsumoto, Roger Rittmaster, Claus Roehrborn, David Russell, Donald Tindall

Research output: Contribution to journal › Article › peer-review

202 Scopus citations

Fingerprint

Dive into the research topics of 'Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences